Botulinum Toxin industry analysis research and trends report for 2020- 2026

-

A research study conducted by Global Market Insights, Inc., suggests that Botulinum Toxin market is likely to exceed the $8.9 billion mark by 2026, in terms of revenue.

Botulinum toxin market trends are likely to be driven by the escalating demand for cosmetic treatment to reduce laxity, facial wrinkles and other non-invasive procedures for beauty enhancement. The pursuit of beauty and youth has undergone a revival of interest as evinced by rise in visits of individuals to cosmetology clinics.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3408

The recent approval of the potent botulinum toxin Dysport, which is the first and only FDA approved toxin for the treatment of lower and upper limb spasticity in both pediatrics and adults, will offer several opportunities for the industry players over the coming years. A report suggests that global botulinum toxin market size will cross the USD 8.9 billion mark by 2026.

Botulinum toxin A is extensively used to treat square jaws, crow’s fee and forehead lines and wrinkles. The product is also used in easing cases of chronic pelvic pain in women with endometriosis. It is also experiencing high adoption for treating muscle spasm. Multiple therapeutic indications of botulinum toxin will boost the product demand over the coming years. In 2019, botulinum toxin A segment dominated the global market in and is set to grow at to 8.9% CAGR over 2020-2026.

Aesthetic surgeries using botulinum toxin show long-lasting results with fewer side effects. Aesthetic applications accounted for 42.4% of the botulinum toxin market share. Increasing preference of patient for aesthetic surgeries which are technologically advanced and carried out under safety parameters may bolster product demand in future.

Request for Customization @ https://www.gminsights.com/roc/3408

Industry revenues from the spa & cosmetic centers are estimated to showcase significant growth rate of 9.2% through 2026. The growth can be attributed to rise in number of cosmetic surgeries performed annually across the globe along with technological advancement in cosmetology which is driving the demand for botulinum toxin products. Moreover, other benefits offered by these centers like de-stressing and relaxation may contribute to the consumption of the chemical.

APAC botulinum toxin market share will garner significant gains through 2026 on account of rising disposable incomes, high growth rate of aging population and associated demand for facial cosmetic treatments. Botulinum toxin products are witnessing high demand in the region due to rising product awareness along with accessibility to new technologies. Moreover, there is rise in number of aesthetic surgeries with the availability of trained plastic surgeons in region.

Browse report summary @ https://www.gminsights.com/industry-analysis/botulinum-toxin-market

Some of the established botulinum toxin providers are Eisai Co., Ltd., Revance Therapeutics, Inc, Hugel Inc., Galderma S.A., Hugh source international ltd., Allergan, Medytox Inc., Merz Pharma and Ipsen, among others.

 

About Global Market Insights:

 

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

 

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/

Comments

Post a Comment

Popular posts from this blog

Laparoscopic Instruments market research report by 2020 to 2026

-
  A research study conducted by Global Market Insights, Inc., suggests that Laparoscopic Instruments market is likely to exceed the $ 20 billion mark by 2026, in terms of revenue. owing to the rising incidence of colorectal cancer. According to reliable estimates, colorectal cancer is the third most common cancer diagnosis with death due to cancer seen in both men and women across industrialized nations. Given the increasing prevalence of cancer cases, the demand for laparoscopic procedures will also increase tremendously, thereby boosting the market growth.   With ongoing technological advancements and new innovations, the laparoscopic instruments market is slated to further witness tremendous growth over the coming years. While robotic surgery is not new in the medical field, new advancements in the field of robotic hardware and software will augment the next gen of tools and instruments that would enhance the skills of physicians and patient outcomes Request for a samp...
Read more

Cancer diagnostics market statistics and research analysis released in latest report

-
  A research study conducted by Global Market Insights, Inc., suggests that Cancer Diagnostics Market is likely to exceed the $170 billion mark by 2025, in terms of revenue. Growing awareness regarding early disease diagnosis coupled with increasing number of diagnostic and research laboratories will drive cancer diagnostics market demand over the forthcoming time period. Evolving healthcare infrastructure of developing countries, rising awareness about cancer, and increasing healthcare spending will further influence the market growth positively. With growing prevalence of cancer cases across the globe, key industry players are increasingly focusing on consolidating their position in the market through several tried-and-tested methods. Citing an instance, on 29 th June 2020, BioCare Medical, a renowned provider of automated, innovative, immunohistochemistry (IHC) instrumentation and reagents, reportedly announced a collaborative partnership with Bethyl Laboratories for developin...
Read more